Benzinga | Jul 20, 2020 08:05AM EDT

Ampio Reports Publication On 'Potential Benefits Of Ampion For Treatment Of New COVID-19 Related Syndrome'

ENGLEWOOD, Colo., July 20, 2020 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE:AMPE),a biopharmaceutical company focused on the development and advancement of immunology based therapies for prevalent inflammatory conditions, todayannounced thepublication "Insights into pediatric multi-system inflammatory syndrome and COVID-19."